Skip to content
← Full study record

NCT00079001 · MORE INFO

Limitations, agreements, and source contact

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases · Source last updated 2020-05-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Must obtain prior Sponsor approval.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
smith.matthew@mgh.harvard.edu
organization
Massachusetts General Hospital
title
Matthew Smith, MD, PhD
Complete source fields
certain Agreement
other Details
Must obtain prior Sponsor approval.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
smith.matthew@mgh.harvard.edu
organization
Massachusetts General Hospital
title
Matthew Smith, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice